1. Prenatal exposure to acetaminophen increases the risk of atopic dermatitis in children: A nationwide nested case-control study in Taiwan.
- Author
-
Li CY, Dai YX, Chang YT, Bai YM, Tsai SJ, Chen TJ, and Chen MH
- Subjects
- Acetaminophen adverse effects, Case-Control Studies, Child, Female, Humans, Pregnancy, Taiwan epidemiology, Dermatitis, Atopic epidemiology, Prenatal Exposure Delayed Effects epidemiology
- Abstract
Background: Acetaminophen (APAP) has been associated with the development of atopic diseases. However, little is known about the relationship between prenatal APAP exposure and atopic dermatitis (AD) in offspring., Objective: To investigate the association between prenatal APAP exposure and AD risk in offspring., Methods: In this study, 2029 study pairs (AD-affected children and their mothers) and 5,058 control pairs were identified between 1998 and 2008 from the Taiwan Longitudinal Health Insurance Database. Maternal APAP exposure during pregnancy was assessed., Results: After adjustment for potential confounders, there was a significant association between risk of offspring AD and exposure to acetaminophen in the first trimester (OR 1.16; 95% CI 1.05-1.28), the second trimester (OR 1.14; 95% CI 1.03-1.27), both first and second trimesters (OR 1.30; 95% CI 1.13-1.51), both first and third trimester (OR 1.20; 95% CI 1.04-1.39), any trimester (OR 1.12; 95% CI 1.00-1.26), and all three trimesters (OR 1.32; 95% CI 1.08-1.62) in a dose-response manner., Conclusions: Prenatal exposure to acetaminophen was associated with an increased incidence of offspring AD., (© 2021 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF